NEWS CENTER

Position:

Group Announcement

Media reports

Group News

Xu Yanzeng visited Guangxiang Pharmaceutical, a subsidiary of Shijiazhuang Fourth Pharmaceutical Group, for a research visit.

Category:

Group News

Time：2022-03-07

On March 3, Xu Yanzeng, Deputy Secretary of the Party Group and Deputy Director of the Hebei Provincial Administration for Market Regulation, as well as Party Secretary and Director of the Provincial Drug Administration, visited enterprises including Hebei Guangxiang Pharmaceutical Co., Ltd. of Shijiazhuang Four Pharmaceutical Group in Cangzhou to conduct research and provide guidance on the development of the pharmaceutical industry and drug safety supervision.

Xu Yanzeng visited Guangxiang Pharmaceutical, a subsidiary of Shijiazhuang Fourth Pharmaceutical Group, for a research visit.

On March 3, Xu Yanzeng, Deputy Secretary of the Party Group and Deputy Director of the Hebei Provincial Administration for Market Regulation, as well as Party Secretary and Director of the Provincial Drug Administration, visited enterprises including Cangzhou Shijiazhuang Sihua Pharmaceutical Group Hebei Guangxiang Pharmaceutical Co., Ltd. to conduct research and provide guidance on the development of the pharmaceutical industry and drug safety supervision.

At the Biopharmaceutical Industry Park in Bohai New Area, Xu Yanzeng and his delegation visited Guangxiang Pharmaceutical, a subsidiary of the group. They listened carefully to a briefing given by Su Xuejun, Chairman of Shijiazhuang Fourth Pharmaceutical Group, on the group’s and Guangxiang Pharmaceutical’s drug R&D efforts, project construction, and production and operational activities. They also gained a comprehensive understanding of the challenges and demands faced by companies located in the park. Xu Yanzeng fully praised Shijiazhuang Fourth Pharmaceutical Group’s Guangxiang Pharmaceutical for seizing the opportunities presented by the coordinated development of the Beijing-Tianjin-Hebei region, accelerating the development of a specialized API industrial chain, and achieving remarkable success—through strengthened quality management—in successfully entering the high-end international market.

Xu Yan emphasized the need to fully implement the “one park, one dedicated team” pairing and liaison mechanism, refine the layout of technology collaboration and innovation platforms for the pharmaceutical and medical device industries in industrial parks, and deepen support and guidance by strengthening services related to review and approval, job skills training, and laboratory testing capacity building. This will help enterprises accelerate the R&D and industrialization of high-end active pharmaceutical ingredients, high-end formulations, and modern Chinese medicines.

Wang Fengshan, Deputy Director of the Provincial Drug Administration Bureau, Li Huafeng, Member of the Standing Committee of the Cangzhou Municipal Party Committee, Secretary of the Party Working Committee and Director of the Management Committee of the Bohai New Area, and Secretary of the Huanghua Municipal Party Committee, along with Feng Yanbin, Director of the Cangzhou Municipal Bureau, accompanied the research team.

Keywords:

The School of Chemical Engineering at Hebei University of Science and Technology is in discussions with the Group regarding university-enterprise cooperation.

Xiaomei Deng, Vice Chair of the Shijiazhuang Municipal Committee of the Chinese People's Political Consultative Conference, pays a visit to and offers condolences to the group’s high-level talents.

The School of Chemical Engineering at Hebei University of Science and Technology is in discussions with the Group regarding university-enterprise cooperation.

Xiaomei Deng, Vice Chair of the Shijiazhuang Municipal Committee of the Chinese People's Political Consultative Conference, pays a visit to and offers condolences to the group’s high-level talents.